Evaluating a Liquid Extract of Carob to Improve Blood Sugar in People With Prediabetes
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversidad Católica San Antonio de Murcia
About this trial
This study evaluates whether a liquid carob extract can improve blood glucose levels in individuals with prediabetes. Participants are selected according to predefined health criteria and randomly assigned to two groups: one group receives the carob extract and the other receives an inert liquid (placebo). Blood samples are collected and glucose-related parameters are measured throughout the study to assess changes over time. The objective is to determine whether this extract may contribute to better glycemic control and help prevent progression to diabetes.
Eligibility criteria
Qualifiers
Subjects of both sexes aged between 18 and 65.
Impaired fasting glucose (100-125 mg/dL)
Glucose intolerance (oral glucose tolerance test with blood glucose between 140-199 mg/dL after 2 hours).
Glycated hemoglobin between 5.7 and 6.4%
Disqualifiers
Use of medications that may interfere with glucose metabolism.
Subjects with a history of any type of liver or kidney disease.
Alcohol consumption greater than 20 g/day.
History of allergic hypersensitivity or poor tolerance to any component of the products under study.
Trial design
Treatments tested in this trial
- Carob extract
- Control product
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Universidad Católica San Antonio de Murcia
Lead sponsor
San Antonio Technologies - San Antonio Catholic University of Murcia
Sponsor institution
Source ClinicalTrials.gov